Talkspace, Inc.

NASDAQ:TALK

Medical - Care Facilities

Healthcare
$5.25 +0.19%

+$0.01 today

Market cap
$879.44M
Beta
1.07
P/E (TTM)
749.9
EPS (TTM)
$0.01
52W Low $2.22High $5.23

Volume 2.41M

Average 2.55M

TALK Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Talkspace, Inc.NASDAQ: TALK

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses growth accelerates

Q1 FY2026 operating expenses of $32.74M rose 34.4% year over year, ahead of the +13.3% change in trailing-twelve-month operating expenses. Sequentially, it rose 41.8% from the prior quarter. Over 3 fiscal years it compounded at -11.5% a year.

Context

  • Operating expenses amounted to 41.6% of revenue in FY2025, down 6.6 pp from a year earlier.
  • Operating expenses increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +34.4% holds above the trailing-twelve-month pace of +13.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$32.74M+41.8% QoQ
Last fiscal yearDec 2025
$95.2M+5.4% YoY
LTMMar 2026
$103.57M+13.3% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+34.4%——
1 year+5.4%——
3-year CAGR-11.5%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
95.2M USD
Year-over-year change
+5.4%
4-year CAGR
-12.3%

Operating Expenses vs competitors

How TALK compares with its peers on the latest reported figures

  • TALK's LTM Mar 2026 operating expenses of $103.57M is the 7th highest of the 11 companies compared; the peer median is $157.3M.
  • Its year-over-year change of +13.3% is the 4th highest of 10, against a peer median of -9.0%.
  • Operating expenses amounts to 43.5% of revenue for TALK, versus a peer median of 56.5%.
TALK Competitors Peer median
Operating Expenses for TALK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYHCommunity Health Systems, Inc.LTM Mar 2026$20.08B +328.5%+39.1%93.5%
AVNSAvanos Medical, Inc.LTM Mar 2026$404.3M +24.4%+5.2%56.5%
KALVKalVista Pharmaceuticals, Inc.LTM Dec 2025$246.68M ——212.8%
CMPSCOMPASS Pathways plcLTM Mar 2026$172.25M -9.0%+17.5%—
INNVInnovAge Holding Corp.LTM Mar 2026$159.23M -12.2%+63.8%16.8%
RIGLRigel Pharmaceuticals, Inc.LTM Mar 2026$155.37M +12.5%-5.0%51.8%
TALKTalkspace, Inc.LTM Mar 2026$103.57M +13.3%-11.5%43.5%
AIRSAirSculpt Technologies, Inc.LTM Mar 2026$103.33M -16.8%-6.2%68.1%
CLPTClearPoint Neuro, Inc.LTM Mar 2026$51.59M +24.6%+16.2%127.0%
NNNNAnbio Biotechnology Class A Ordinary SharesFY2025$2M -48.5%-5.4%20.5%
SNDASonida Senior Living, Inc.LTM Mar 2026-$38.53M -111.0%-51.3%9.4%
Peer median (excluding TALK) $157.3M-9.0%+5.2%56.5%

Competitors are the stored peer set for TALK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue113.67M119.57M150.05M187.59M228.87M
Cost of Revenue46.9M59.23M75.67M101.76M130.52M
Gross Profit66.77M60.34M74.38M85.84M98.35M
Gross Margin58.7%50.5%49.6%45.8%43.0%
Research & Development15.92M21.66M17.57M10.51M9.54M
Selling, General & Admin135.41M109.11M73.86M73.28M75.57M
Operating Expenses160.7M137.36M97.59M90.33M95.2M
Depreciation & Amortization1.97M1.36M1.2M859K2.88M
EBITDA(60.72M)(78.06M)(17.77M)2.1M11.24M
EBITDA Margin-53.4%-65.3%-11.8%1.1%4.9%
Operating Income(93.92M)(77.02M)(23.21M)(4.5M)3.15M
Operating Margin-82.6%-64.4%-15.5%-2.4%1.4%
Interest Income31.23M3.74M4.25M5.74M5.22M
Interest Expense00000
Other Income / Expenses31.23M(2.39M)4.25M5.74M5.22M
Income Before Tax(62.7M)(79.42M)(18.96M)1.24M8.37M
Pre-Tax Margin-55.2%-66.4%-12.6%0.7%3.7%
Income Tax Expense47K254K218K94K574K
Net Income(62.74M)(79.67M)(19.18M)1.15M7.79M
Net Margin-55.2%-66.6%-12.8%0.6%3.4%
EPS (Basic)(0.72)(0.51)(0.12)0.010.05
EPS (Diluted)(0.72)(0.51)(0.12)0.010.04
Weighted Avg Shares154.08M156.89M165.04M168.91M168.43M
Weighted Avg Shares (Diluted)154.08M156.89M165.04M176.5M173.75M

Talkspace, Inc.

NASDAQ:TALK

Intrinsic Alpha fair value

Locked

Current Price

$5.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.